CI-MGP @EC2609A

LEOCH INT'L

STARGLORY HLDGS

INTELLIMARK W27

BEST FOOD HLDG

GAOYU FINANCE

EXTREME VISION

TIAN TU CAPITAL

HSC RESOURCES

EPI (HOLDINGS)

LAP KEI ENGRG

01318

Jefferies has maintained a Buy rating on Mao Geping Cosmetics Co., Ltd. Class H (1318), setting a price target of HK$100.00, while the shares closed at HK$74.40. Analyst Boya Zhen has an average return of -15.1% and an 11.11% success rate. The overall analyst consensus is a Strong Buy with an average price target of HK$105.10, indicating a potential upside of 41.26%. Morgan Stanley also supports a Buy rating with a HK$100.00 target.

Tip Ranks

MAO GEPING

Jefferies Keeps Their Buy Rating on Mao Geping Cosmetics Co., Ltd. Class H (1318)

Citi has maintained a Buy rating on Mao Geping Cosmetics Co., Ltd. Class H (1318) with a price target of HK$97.90, as reported on March 28. Additionally, Goldman Sachs also issued a Buy rating on March 27. Conversely, UBS has a Hold rating for the same company.

Citi Keeps Their Buy Rating on Mao Geping Cosmetics Co., Ltd. Class H (1318)

Jefferies Adjusts Mao Geping Cosmetics' Price Target to HK$100 From HK$117, Keeps at Buy

marketscreener

Jefferies Adjusts Mao Geping Cosmetics' Price Target to HK$100 From HK$117, Keeps at Buy

HSBC Research has lowered the target price for MAO GEPING to 102.4 yuan, maintaining a "Buy" rating. Although the performance for 2025 meets expectations, it is slightly below expectations due to the slowdown in offline channel growth and the increase in sales cost ratio. Management has set a revenue growth target of 30% for 2026, which is expected to be achievable, but intensified competition in online channels may impact profitability. The net profit for 2025 is expected to grow by 37%, with revenue growth of 30%. The net profit forecasts for 2026 and 2027 have both been lowered by 7.5%. The new target price corresponds to a forecasted price-to-earnings ratio of 26.9 times for 2027

AASTOCKS

"Da Xing" Huizheng lowered MAO GEPING's target price to 102.4 yuan, rating "Buy"

Mao Geping Cosmetics' Profit, Revenue Jump in 2025; Shares Rise 9%

Mao Geping Cosmetics' Profit, Revenue Jump in 2025; Shares Rise 9%

09992

01880

00700

01024

03690

06693

06862

02252

On March 27th, during intraday trading of Hong Kong stocks, the three major indices maintained a narrow range of fluctuations and have not yet broken through the peak level reached on March 25th. In terms of sectors, retail stocks performed steadily, while the internet and catering sectors showed divergent trends. MAO GEPING rose over 11%, leading the popular stocks, with Tencent and Meituan having high trading volumes, and the overall market sentiment remained cautious

- On March 27, during trading, Hong Kong's three major indices saw slight increases, maintaining a fluctuating trend.  
- The Hang Seng Index reported 24,860.82, up 0.02%, yet failed to reach new highs from March 25, while retail sectors showed slight gains due to stable consumer demand.  
- The macroeconomic context remains focused on trade data and unemployment rates, with expectations of policy support rising as investors seek clearer recovery signals.

Market Heartbeat

POP MART

CTG DUTY-FREE

TENCENT

KUAISHOU-W

MEITUAN

CHIFENG GOLD

HAIDILAO

MircroPort Medbot-B

Hong Kong stock market intraday | The Hang Seng Index rose slightly, the retail sector strengthened, MAO GEPING rose 11.56%

For MAO GEPING (1318.HK), the current market conditions show some potential dangers. In terms of technical indicators, the death cross formed by the MACD indicates that a market adjustment may be imminent. This technical signal is typically a bearish indicator, suggesting that the market may quickly enter a more volatile phase, and the stock may face greater downward pressure. From the perspective of capital flow, the interaction of investor behavior with technical signals demonstrates a lack of strong and diversified capital inflows in the market. This situation has led to no significant increase in trading volume, which is a clear indication of strong market hesitation. The more defensively investors adjust their positions, the more the market tends to consolidate rather than actively enter. Therefore, whether MAO GEPING can significantly improve its market conditions in the coming trading days will be a key focus in the short-term market. In the absence of new stimulating factors, seeking broader market confidence and capital support may help improve the overall trend of the moving average cross downward. Investors need to closely monitor changes in technical signals to respond to potential market turning points

Technical Forecast

MAO GEPING (1318.HK) faces short-term market mobility risks

Mao Geping Cosmetics Completes Conversion of Unlisted Stock into Hong Kong Shares

Mao Geping Cosmetics Completes Conversion of Unlisted Stock into Hong Kong Shares

Morgan Stanley released a research report, stating that MAO GEPING aligns with China's K-shaped consumption model and is less affected by geopolitical factors. The recent stock price adjustment is mainly due to fluctuations in sales during the Lunar New Year and market risk aversion, providing a long-term investment opportunity. The bank expects a price-to-earnings ratio of 21 times in 2026, with an average annual compound growth rate of about 25% in earnings from 2025 to 2027; it gives an "Overweight" rating with a target price of 100 yuan, listing it as the top choice in China's beauty industry

Morgan Stanley: MAO GEPING's recent pullback provides an entry opportunity with a target price of 100 yuan, urging to "increase holdings."

Mao Geping Cosmetics Gets Hong Kong Bourse Nod to List Converted Shares

Mao Geping Cosmetics Gets Hong Kong Bourse Nod to List Converted Shares

Reuters

Mao Geping Cosmetics Receives Stock Exchange Approval for H Share Full Circulation

On July 11, the three major stock indices in Hong Kong rose together. In terms of sectors, technology stocks rose collectively, and securities and brokerage stocks mostly increased.

CPIC

ZA ONLINE

LAOPU GOLD

MIXUE GROUP

GUMING

WUXI APPTEC

WuXi AppTec

AIA Group

LIANLIAN

OSL GROUP

HENGRUI PHARMA

Hengrui Pharma

PICC P&C

BLOKS

PING AN

Ping An Ins HK SDR2to1

Ping An

Ping An Insurance

CITIC SEC

CITIC Securities Co., Ltd.

EB SECURITIES

EBSCN

WUXI BIO

WuXi Biologics

CHINA LIFE

China Life

CHICMAX

XIAOMI-W

Xiaomi HK SDR 2to1

Xiaomi Corporation

AKESO

CHINA EB LTD

GUOTAI JUNAN I

BEONE MEDICINES

BeOne Medicines

Beigene

REMEGEN

RemeGen

LINKLOGIS-W

CICC

Circle

The Hang Seng Index is approaching its highest level in nearly 3 years, with Chinese brokerage, insurance, and stablecoin concept stocks remaining hot!

A cup of milk tea costs 4 yuan, but a share of the Snow King is over 200+! (There’s a little surprise at the end, make sure to read to the end!) MIXUE GROUP, which operates Mixue Ice City, will start its IPO from February 21 to 26, planning to issue 17.06 million shares, with 10% available for public sale in Hong Kong. The offering price is 202.5 yuan, with a minimum purchase of 100 shares, and the entry fee is over 20,000 yuan (for the Phantom Vision Bruker 2.0). The fundraising target is 3.45 billion yuan, with a net fundraising of 3.291 billion yuan, and the entry fee for one lot of 100 shares is 20,454.2 yuan...

Luckin Coffee

【New Stock Highlights】Snow King is here! The entry fee for Mixue Ice City is over 20,000, expensive but worth it?

$BLOKS(00325.HK)$MAO GEPING(01318.HK) Thanks again to Longbridge, the IPO was very enjoyable 😆😆😆 There are still two certain opportunities, Mixue Ice City and KAYOU

$MINIEYE(02431.HK) has a new IPO, with Mao Ge Ping's jewelry as a precedent. Will this stock surge? Here are some summarized viewpoints:First, this time the cornerstone investors are almost fully subscribed, accounting for 74%, with Kang Cheng Heng International Investment Co., Ltd. holding 72.5%, and Horizon Together Holding Ltd. symbolically investing a bit, accounting for 1.6%.Second, this time it is sponsored by CITIC, and historically, sponsored IPOs have rarely broken. If CITIC locks in the cornerstone investors without reallocating to the public, then the higher the subscription multiple, the better. At most, only 26% of the shares will be allocated back to the public, amounting to nearly 200 million worth of shares.

CITIC

MINIEYE

$MAO GEPING(01318.HK) missed out on Laopu Gold, but returned a 50%+ dark market for me, thank you Longbridge😍 If the funds operate according to Laopu Gold, then the big profits are still ahead.Coincidentally, the mainland has also decided to ease monetary policy, is the Chinese concept preparing for an inflation bull? $Direxion FTSE China Bull 3X(YINN.US)

Direxion FTSE China Bull 3X

$MAO GEPING(01318.HK) I heard it's one person per hand, everyone has a share! If it's true, it definitely won't rise much. 😓😓Is there anyone who didn't win? Please verify!

$MAO GEPING(01318.HK) feels like it's not that hot, will check the excess multiple later $GIANT BIOGENE(02367.HK)

GIANT BIOGENE

$MAO GEPING(01318.HK) feels like this is the next old shop gold, ready to take a shot at the new.

CI-MGP @EC2609A(27441.HK)

CI-MGP @EC2609A Stock Performance Chart

Jefferies Keeps Their Buy Rating on Mao Geping Cosmetics Co., Ltd. Class H (1318)

Citi Keeps Their Buy Rating on Mao Geping Cosmetics Co., Ltd. Class H (1318)

Jefferies Adjusts Mao Geping Cosmetics' Price Target to HK$100 From HK$117, Keeps at Buy

"Da Xing" Huizheng lowered MAO GEPING's target price to 102.4 yuan, rating "Buy"

Mao Geping Cosmetics' Profit, Revenue Jump in 2025; Shares Rise 9%